Products for Research Use Only
RegisterLogin

Batifiban (TFA)

CAT: 0804-HY-125053A-01Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-125053A-01Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Batifiban TFA, a cyclic peptide, is an antagonist of platelet glycoprotein GPIIb/IIIa and inhibits platelet aggregation. Batifiban blocks the binding of circulating vitronectin to integrin ανβ3[1].
UNSPSC
12352209
Target
Glycoprotein VI
Type
Peptides
Related Pathways
Immunology/Inflammation
Applications
Neuroscience-Neuromodulation
Field of Research
Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/batifiban-tfa.html
Purity
99.70
Solubility
10 mM in DMSO
Smiles
O=C(N1[C@@](C(N[C@@H](CSSCCC2=O)C(N)=O)=O)([H])CCC1)[C@@H](NC([C@@H](NC(CNC([C@@H](N2)CCCNC(N)=N)=O)=O)CC(O)=O)=O)CC3=CNC4=CC=CC=C34.OC(C(F)(F)F)=O.[x]
Molecular Formula
C34H47N11O9S2.xC2HF3O2
Molecular Weight
817.94 (free base)
References & Citations
[1]Chen H, et al. Safety, pharmacokinetic and pharmacodynamic studies of batifiban injection following single- and multiple-dose administration to healthy Chinese subjects. J Huazhong Univ Sci Technolog Med Sci. 2009 Feb;29 (1) :12-8. [Content Brief]
Shipping Conditions
Blue Ice
Storage Conditions
-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture and light)
Scientific Category
Peptides
Clinical Information
No Development Reported

Related Products

CatalogName
HY-125053Batifiban
HY-P5380ATNO211 (TFA)
HY-P4668A-01Valylleucine (TFA)
HY-P11296A-01LLVK (TFA)
HY-P10927A-01BRP (TFA)
HY-P10333A-01LIH383 (TFA)
HY-P3970D-01KQFK (TFA)
HY-P3460A-01TDSRCVIGLYHPPLQVY (TFA)
HY-P1723ASpexin (TFA)
HY-P10471A-01MPSD (TFA)

Alternative Products

CatalogName
MBS5824569Batifiban TFA
T26739Batifiban
A8967-1EZM0414 TFA
C8651-10Pentosidine TFA
A8958-100Box5 TFA
B5867-200SCH772984 TFA
B8792-5GsMTx4 TFA
CS-O-15602Doxorubicinol TFA
PP50168-01Apraglutide TFA
330135Gardiquimod TFA

Popular Products